DOCSLIB.ORG

Characterization of Enterocin 1146, a Bacteriocin from Enterococcus Faecium Inhibitory to Listeria Monocytogenes

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Characterization of Enterocin 1146, a Bacteriocin from Enterococcus Faecium Inhibitory to Listeria Monocytogenes 497 Journal of Food Protection, Vol. 55, No. 7, Pages 497-502 (July 1992) Copyright©, International Association of Milk, Food and Environmental Sanitarians Characterization of Enterocin 1146, a Bacteriocin from Enterococcus faecium Inhibitory to Listeria monocytogenes EUGENIO PARENTE1 and COLIN HILL* The National Dairy Products Research Centre, Moorepark, Fermoy, Co. Cork, The Irish Republic Downloaded from http://meridian.allenpress.com/jfp/article-pdf/55/7/497/1661676/0362-028x-55_7_497.pdf by guest on 25 September 2021 (Received for publication November 12, 1991) ABSTRACT cultures has been proposed for Cheddar cheese (37), Fontina cheese (6), and water-buffalo Mozzarella cheese (57). Enterococcus faecium DPC 1146 produces a bacteriocin, In this report we describe the characterization of enterocin 1146, which is inhibitory to Listeria monocytogenes. Enterocin 1146 was produced in GM17 and in milk. The bacterio­ enterocin 1146, a bacteriocin produced by E. faecium cin was partially purified by ammonium sulfate precipitation. Its DPC1146, which is relatively specific to Listeria spp. molecular weight, estimated by SDS-PAGE, was 3.0 kDa. It could be stored at -20°C without loss of activity, but pH had a marked MATERIALS AND METHODS effect on enterocin 1146, which was more stable at both high (up to 120°C) and low temperatures (4°C) at pH 5 than at pH 7 and Strains and media 9. The sensitivity of 57 strains belonging to 35 different species Enterocin 1146 is produced by E. faecium DPC1146. Unless was studied using a critical dilution assay. L. monocytogenes and otherwise noted L. innocua DPC 1770 was used as the indicator L. innocua were most sensitive; enterocin 1146 had a bactericidal strain. A complete list of the strains, their growth media, and effect on Listeria. Starter and nonstarter lactic acid bacteria temperature of incubation used in this study is shown in Table 1. (except Lactobacillus sake) were insensitive or relatively resistant All strains were maintained frozen at -80°C in 25% glycerol. to the bacteriocin. Genetic determinants for bacteriocin production Enterococci were routinely propagated in GM17 (M17, Difco and immunity do not appear to be plasmid borne. Laboratories, Detroit, MI + 0.5% glucose). GM17 dialysate (DGM17) was prepared by dissolving M17 in water with the appropriate amount of glucose at 10X concentration. The solution was then dialyzed against sterile distilled water and the permeate Bacteriocins are bacterial proteins which are usually, was sterilized and used as a growth medium. but not always, inhibitory to species and strains closely related to the producer. Several bacteriocins produced by Measurement of bacteriocin activity lactic acid bacteria have been characterized (27). While A critical dilution assay was used. Culture supernatant or most have a narrow inhibitory spectrum, some, like pediocin filter sterilized bacteriocin solutions were serially diluted (two­ A (77), pediocin PA-1 (32), pediocin AcH (8), sakacin A fold) in GM17 broth, and 10 ul aliquots were spotted on GM17 (34), are also active against foodborne pathogens, like plates and dried for 30 min. The plates were overlaid with 3 ml (7 ml for Clostridia) of the appropriate soft (0.7% agar) medium, Listeria monocytogenes, and thus have a potential as natu­ preinoculated with 0.1 ml of an overnight culture of the indicator, ral food preservatives. and incubated at the appropriate temperature. One arbitrary unit The ability of enterococci to produce bacteriocins, (AU) was defined as the reciprocal of the highest dilution of some of which display a broad inhibitory spectrum, is well enterocin 1146 giving a zone of inhibition on the indicator lawn known (9). Enterocin E1A, a well-characterized bacteriocin (32). When a clear inhibition zone was followed by a turbid one, from Enterococcus faecium (22,23), has been shown to be the critical dilution was taken to be the average of the final two active against Listeria (3). According to a number of recent dilutions. reports (2,26), the ability to inhibit L. monocytogenes may be relatively widespread among enterococci. Enterococci Bacterial counts Viable bacterial cells were enumerated using a Spiral Plater have caused foodborne infections only in very rare in­ (Spiral Systems, Inc., Cincinnati, OH). E. faecium DPC1146 was stances and evidence on their role as foodborne pathogens enumerated on GM17 agar after incubation for 24 h at 37°C. L. are scant or lacking (20). They can be isolated from innocua DPC 1770 was enumerated on trypticase soy agar (BBL artisanal cheeses and starters (70), and their use in starter Microbiology Systems, Cockeysville, MD) + 0.6% yeast extract (Oxoid, Ltd., Basingstoke, Hampshire, England) after incubation for 48 h at 30°C. Colonies were enumerated using a Protos ' Present address: Dipartimento di Biologia, Difesa e Biotecnologie Colony Counter (Ai Cambridge, Ltd; Pannisford, Cambridge, Agro-Forestali, Universita' della Basilicata, 85100 Potenia Italy. England). JOURNAL OF FOOD PROTECTION, VOL. 55, JULY 1992 498 PARENTE AND HILL Table 1. Bacterial strains, media, and temperature of incubation used in this study. Relative sensitivity of a strain to partially purified enterocin 1146 (ppE1146) is calculated as the ratio between the activity of the bacteriocin (AU/ml) using that strain as indicator to that obtained on L. innocua DPC 1770 (76800 AU/ml). Strain Medium1 Temp. (°C) Source2 Relative sensitivity Bacillus cereus ATCC9139 TSB 37 TNO 0 B. subtilis BD630 TSB 37 RuG 0 B. subtilis OG1 TSB 37 RuG 0 Clostridium butyricum NCD01713 RCM 30 DPC 0.083 C. sporogenes NCD01789 RCM 37 DPC 0 C. sporogenes C 22/10 RCM 37 TNO 0 C. perfringens NCDO1800 RCM 37 DPC 0.032 C. tyrobutyricum NCD01754 RCM + SL 30 TNO 0 C. tyrobutyricum NCD01756 RCM + SL 30 DPC 0 C. tyrobutyricum NCDO1790 RCM + SL 30 DPC 0 C. tyrobutyricum 3.5 RCM + SL 30 TNO 0 Enterococcus faecium DPC 11463 GM17 37 DPC 0 Downloaded from http://meridian.allenpress.com/jfp/article-pdf/55/7/497/1661676/0362-028x-55_7_497.pdf by guest on 25 September 2021 E. faecium DPC3342" GM17 37 DPC 0.004 E. faecalis NCD0581 GM17 37 DPC 0.063 E. faecalis NCDO610 GM17 37 DPC 0.063 £./aeca/isDPC1142 GM17 37 DPC 0.063 E. faecalis 1 GM17 37 TNO 0.042 Lactobacillus acidophilus ATCC4356 MRS 37 TNO 0 L. casei ATCC334 MRS 37 TNO 0 L. casei ssp. pseudoplantarum DPC2136 MRS 37 DPC 0 L. curvatus NCFB2739 MRS 30 TNO 0.001 L. delbrueckii subsp. bulgaricus ATCC1184 MRS 42 TNO 0.002 L. delbrueckii subp. lactis DPC 1125 MRS 37 DPC 0 L. fermentum ATCC9338 MRS 37 TNO 0 L. helveticus ATCC15009 MRS 42 TNO 0 L. helveticus DPC 1130 MRS 42 DPC 0.005 L. plantarum NCD01193 MRS 37 TNO 0.001 L. reuteri DSM20016 MRS 37 TNO 0 L. sake NCFB2714 MRS 30 TNO 0.500 L. salivarius NCFB2747 MRS 37 TNO 0 Lactococcus lactis subsp. lactis MG1614 GM17 30 DPC 0.063 L. lactis subsp. lactis DPC2612 GM17 30 DPC 0 L. lactis subsp. lactis bv. diacetylactis DPC938 GM17 30 DPC 0 L. lactis subsp. lactis bv. diacetylactis DPC979 GM17 30 DPC 0 L. lactis subsp. lactis bv. diacetylactis DPC990 GM17 30 DPC 0 L. lactis subsp. lactis bv. diacetylactis DRC3 GM17 30 DPC n.t.5 L. lactis subsp. cremoris DPC2645 GM17 30 DPC 0 L. lactis subsp. cremoris CNRZ117 GM17 30 TNO 0 Leuconostoc cremoris DB1275 MRS 25 TNO 0 Leuconostoc subsp. DPC225 MRS 25 TNO 0 Leuconostoc subsp. DPC 1061 MRS 25 DPC 0 Listeria innocua DPC 1770 TSB YE 30 DPC 1 L. innocua BL86/26 TSB YE 30 TNO 0.667 L. monocytogenes 9 TSB YE 30 DPC 0.500 L. monocytogenes DPC 1771 TSBYE 30 DPC 0.667 L. monocytogenes NCTC5348 TSB YE 30 DPC 4.000 L. monocytogenes Scott A TSBYE 30 DPC 1 Pediococcus pentosaceus FBB63 MRS 30 TNO 0.083 P. pentosaceus PCI MRS 30 TNO 0 P. acidilactici NCFB2767 MRS 30 DPC 0.002 Propionibacterium acidipropionici NCFB563 YGL 30 Cranfield 0 Propionibacterium spp. P4 YGL 30 Cranfield 0 Propionibacterium spp. P6 YGL 30 Cranfield 0 Salmonella typhimurium ATCC 14028 TSB 37 DPC 0 Staphylococcus aureus DPC 1772 TSB 37 DPC 0 S. carnosus MCI TSB 37 TNO 0 Streptococcus thermophilus DPC 1780 GM17 37 DPC 0 S. thermophilus DPC2227 GM17 37 DPC 0 RCM = Reinforced clostridial medium (Oxoid Ltd.); RCM + SL = RCM + 0.5% sodium lactate (BDH Chemicals Ltd.); TSB = trypticase soy broth (BBL Microbiology Systems); TSBYE = TSB + 0.6% yeast extract (Oxoid); GM17 = M17 (Difco Laboratories) + 0.5% dextrose (Oxoid); MRS from Difco; YGL = Yeast Glucose Lemco Broth (29). Top and bottom media for the critical dilution assay used for the measurement of sensitivity were obtained adding, respectively, 0.7% and 1.5% agar bacteriological to the broth media listed. TNO: Dr. B. ten Brink, TNO Nutrition and Food Research, Zeist, The Netherlands. RuG: Prof. G. Venema, University of Groningen, The Netherlands. DPC: National Dairy Products Research Centre, Moorepark, Fermoy, Co. Cork. Cranfield: Cranfield Institute of Technology, Cranfield Bedford, England. Producer of enterocin 1146. Bac- derivative of DPC 1146. Not tested. JOURNAL OF FOOD PROTECTION, VOL. 55, JULY 1992 BACTERIOCIN FROM ENTEROCOCCUS FAECIUM 499 Production of enterocin 1146 in different media Adsorption of enterocin 1146 to sensitive and resistant cells An overnight culture of E. faecium DPCl 146 was used to Cells from an overnight culture of L. innocua DPCl770 were inoculate (105 CFU/ml) GM17 broth, 10% skim milk (Oxoid), and collected by centrifugation, washed twice in 50 mM potassium Elliker lactic broth (12). The inoculated media were incubated at phosphate buffer, pH 7, and then diluted 1:10 in the same buffer 37°C, and samples were removed for the measurement of bacte­ (obtaining 2.7 x 10s CFU/ml). Controls were buffer alone or cell riocin activity and viable cell counts.
Load more

Recommended publications
  • Probiotic Properties of Enterococcus Faecium CE5-1 Producing A
    Czech J. Anim. Sci., 57, 2012 (11): 529–539 Original Paper Probiotic properties of Enterococcus faecium CE5-1 producing a bacteriocin-like substance and its antagonistic effect against antibiotic-resistant enterococci in vitro K. Saelim1, N. Sohsomboon1, S. Kaewsuwan2, S. Maneerat1 1Department of Industrial Biotechnology, Faculty of Agro-Industry, Prince of Songkla University, Hat Yai, Thailand 2Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai, Thailand ABSTRACT: A bacteriocin-like substance (BLS) producing Enterococcus faecium CE5-1 was isolated from the gastrointestinal tract (GIT) of Thai indigenous chickens. Investigations of its probiotic potential were carried out. The competition between the BLS probiotic strain and antibiotic-resistant enterococci was also studied. Ent. faecium CE5-1 exhibited a good tolerance to pH 3.0 after 2 h and in 7% fresh chicken bile after 6 h, but the viability of Ent. faecium CE5-1 decreased by about 2–3 log CFU/ml after 2 h incubation in pH 2.5. It was susceptible to the antibiotics tested (tetracycline, erythromycin, penicillin G, and vancomycin). The maximum BLS production from Ent. faecium CE5-1 was observed at 15 h of cultivation. It showed activity against Listeria monocytogenes DMST17303, Pediococcus pentosaceus 3CE27, Lactobacillus sakei subsp. sakei JCM1157, and antibiotic-resistant enterococci. The detection by polymerase chain reaction (PCR) in the enterocin structural gene determined the presence of enterocin A gene in Ent. faecium CE5-1 only. Ent. faecium CE5-1 showed the highest inhibitory activity against two antibiotic-resistant Ent. faecalis VanB (from 6.68 to 4.29 log CFU/ml) and Ent.
    [Show full text]
  • Detection of ESKAPE Pathogens and Clostridioides Difficile in Simulated
    bioRxiv preprint doi: https://doi.org/10.1101/2021.03.04.433847; this version posted March 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Detection of ESKAPE pathogens and Clostridioides difficile in 2 Simulated Skin Transmission Events with Metagenomic and 3 Metatranscriptomic Sequencing 4 5 Krista L. Ternusa#, Nicolette C. Keplingera, Anthony D. Kappella, Gene D. Godboldb, Veena 6 Palsikara, Carlos A. Acevedoa, Katharina L. Webera, Danielle S. LeSassiera, Kathleen Q. 7 Schultea, Nicole M. Westfalla, and F. Curtis Hewitta 8 9 aSignature Science, LLC, 8329 North Mopac Expressway, Austin, Texas, USA 10 bSignature Science, LLC, 1670 Discovery Drive, Charlottesville, VA, USA 11 12 #Address correspondence to Krista L. Ternus, [email protected] 13 14 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.03.04.433847; this version posted March 4, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 15 1 Abstract 16 Background: Antimicrobial resistance is a significant global threat, posing major public health 17 risks and economic costs to healthcare systems. Bacterial cultures are typically used to diagnose 18 healthcare-acquired infections (HAI); however, culture-dependent methods provide limited 19 presence/absence information and are not applicable to all pathogens.
    [Show full text]
  • Current Trends of Enterococci in Dairy Products: a Comprehensive Review of Their Multiple Roles
    foods Review Current Trends of Enterococci in Dairy Products: A Comprehensive Review of Their Multiple Roles Maria de Lurdes Enes Dapkevicius 1,2,* , Bruna Sgardioli 1,2 , Sandra P. A. Câmara 1,2, Patrícia Poeta 3,4 and Francisco Xavier Malcata 5,6,* 1 Faculty of Agricultural and Environmental Sciences, University of the Azores, 9700-042 Angra do Heroísmo, Portugal; [email protected] (B.S.); [email protected] (S.P.A.C.) 2 Institute of Agricultural and Environmental Research and Technology (IITAA), University of the Azores, 9700-042 Angra do Heroísmo, Portugal 3 Microbiology and Antibiotic Resistance Team (MicroART), Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5001-801 Vila Real, Portugal; [email protected] 4 Associated Laboratory for Green Chemistry (LAQV-REQUIMTE), University NOVA of Lisboa, 2829-516 Lisboa, Portugal 5 LEPABE—Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, 420-465 Porto, Portugal 6 FEUP—Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal * Correspondence: [email protected] (M.d.L.E.D.); [email protected] (F.X.M.) Abstract: As a genus that has evolved for resistance against adverse environmental factors and that readily exchanges genetic elements, enterococci are well adapted to the cheese environment and may reach high numbers in artisanal cheeses. Their metabolites impact cheese flavor, texture, Citation: Dapkevicius, M.d.L.E.; and rheological properties, thus contributing to the development of its typical sensorial properties. Sgardioli, B.; Câmara, S.P.A.; Poeta, P.; Due to their antimicrobial activity, enterococci modulate the cheese microbiota, stimulate autoly- Malcata, F.X.
    [Show full text]
  • Methicillin-Resistant Staphylococcus Aureus (MRSA)
    Methicillin-Resistant Staphylococcus Aureus (MRSA) Over the past several decades, the incidence of resistant gram-positive organisms has risen in the United States. MRSA strains, first identified in the 1960s in England, were first observed in the U.S. in the mid 1980s.1 Resistance quickly developed, increasing from 2.4% in 1979 to 29% in 1991.2 The current prevalence for MRSA in hospitals and other facilities ranges from <10% to 65%. In 1999, MRSA accounted for more than 50% of all Staphylococcus aureus isolates within U.S. intensive care units.3, 4 The past years, however, outbreaks of MRSA have also been seen in the community setting, particularly among preschool-age children, some of whom have attended day-care centers.5, 6, 7 MRSA does not appear to be more virulent than methicillin-sensitive Staphylococcus aureus, but certainly poses a greater treatment challenge. MRSA also has been associated with higher hospital costs and mortality.8 Within a decade of its development, methicillin resistance to Staphylococcus aureus emerged.9 MRSA strains generally are now resistant to other antimicrobial classes including aminoglycosides, beta-lactams, carbapenems, cephalosporins, fluoroquinolones and macrolides.10,11 Most of the resistance was secondary to production of beta-lactamase enzymes or intrinsic resistance with alterations in penicillin-binding proteins. Staphylococcus aureus is the most frequent cause of nosocomial pneumonia and surgical- wound infections and the second most common cause of nosocomial bloodstream infections.12 Long-term care facilities (LTCFs) have developed rates of MRSA ranging from 25%-35%. MRSA rates may be higher in LTCFs if they are associated with hospitals that have higher rates.13 Transmission of MRSA generally occurs through direct or indirect contact with a reservoir.
    [Show full text]
  • Transfer of Streptococcus Faecalis and Streptococcus Faecium to the Genus Enterococcus Norn
    INTERNATIONALJOURNAL OF SYSTEMATICBACTERIOLOGY, Jan. 1984, p. 31-34 Vol. 34, No. 1 OO20-7713/84/010031-04$02.00/0 Copyright 0 1984, International Union of Microbiological Societies Transfer of Streptococcus faecalis and Streptococcus faecium to the Genus Enterococcus norn. rev. as Enterococcus faecalis comb. nov. and Enterococcus faecium comb. nov. KARL H. SCHLEIFER* AND RENATE KILPPER-BALZ Lehrstuhl fur Mikrobiologie, Technische Universitat Miinchen, D-8000 Miinchen 2, Federal Republic of Germany The results of deoxyribonucleic acid-deoxyribonucleic acid and deoxyribonucleic acid-ribosomal ribonu- cleic acid hybridization studies demonstrated that Streptococcus faecalis and Streptococcus faecium are distantly related to the non-enterococcal streptococci (Streptococcus hovis and Streptococcus equinus) of serological group D and to other streptococci. On the basis of our results and those of previous studies, we propose that S. faecalis and S. faecium be transferred to the genus Enterococcus (ex Thiercelin and Jouhaud) nom. rev. as Enterococcus faecalis (Andrewes and Horder) comb. nov. and Enterococcus faecium (Orla-Jensen) comb. nov., respectively. A description of the genus Enterococcus nom. rev. and emended descriptions of E. faecalis and E. faecium are given. The streptococci belonging to serological group D can be De Ley (4) and were corrected to the value for the reference divided into two physiologically different groups. Strepto- Escherichia coli K-12 DNA. coccus faecalis and Streptococcus faecium were placed in the enterococcus division of the streptococci, whereas RESULTS AND DISCUSSION Streptococcus bovis and Streptococcus equinus were placed in the viridans division by Sherman (21). Kalina proposed (9) The DNA base compositions, serological groups, and that Streptococcus faecalis and Streptococcus faecium peptidoglycan types of the test strains are shown in Table 1.
    [Show full text]
  • Identification, Properties, and Application of Enterocins Produced by Enterococcal Isolates from Foods
    IDENTIFICATION, PROPERTIES, AND APPLICATION OF ENTEROCINS PRODUCED BY ENTEROCOCCAL ISOLATES FROM FOODS THESIS Presented in Partial Fulfillment of the Requirement for the Degree Master of Science in the Graduate School of The Ohio State University By Xueying Zhang, B.S. ***** The Ohio State University 2008 Master Committee: Approved by Professor Ahmed E. Yousef, Advisor Professor Hua Wang __________________________ Professor Luis Rodriguez-Saona Advisor Food Science and Nutrition ABSTRACT Bacteriocins produced by lactic acid bacteria have gained great attention because they have potentials for use as natural preservatives to improve food safety and stability. The objectives of the present study were to (1) screen foods and food products for lactic acid bacteria with antimicrobial activity against Gram-positive bacteria, (2) investigate virulence factors and antibiotic resistance among bacteriocin-producing enterooccal isolates, (3) characterize the antimicrobial agents and their structural gene, and (4) explore the feasibility of using these bacteriocins as food preservatives. In search for food-grade bacteriocin-producing bacteria that are active against spoilage and pathogenic microorganisms, various commercial food products were screened and fifty-one promising Gram-positive isolates were studied. Among them, fourteen food isolates with antimicrobial activity against food-borne pathogenic bacteria, Listeria monocytogenes and Bacillus cereus, were chosen for further study. Based on 16S ribosomal RNA gene sequence analysis, fourteen food isolates were identified as Enterococcus faecalis, and these enterococcal isolates were investigated for the presence of virulence factors and antibiotic resistance through genotypic and phenotypic screening. Results indicated that isolates encoded some combination of virulence factors. The esp gene, encoding extracellular surface protein, was not detected in any of the isolates.
    [Show full text]
  • Characterization of an Endolysin Targeting Clostridioides Difficile
    International Journal of Molecular Sciences Article Characterization of an Endolysin Targeting Clostridioides difficile That Affects Spore Outgrowth Shakhinur Islam Mondal 1,2 , Arzuba Akter 3, Lorraine A. Draper 1,4 , R. Paul Ross 1 and Colin Hill 1,4,* 1 APC Microbiome Ireland, University College Cork, T12 YT20 Cork, Ireland; [email protected] (S.I.M.); [email protected] (L.A.D.); [email protected] (R.P.R.) 2 Genetic Engineering and Biotechnology Department, Shahjalal University of Science and Technology, Sylhet 3114, Bangladesh 3 Biochemistry and Molecular Biology Department, Shahjalal University of Science and Technology, Sylhet 3114, Bangladesh; [email protected] 4 School of Microbiology, University College Cork, T12 K8AF Cork, Ireland * Correspondence: [email protected] Abstract: Clostridioides difficile is a spore-forming enteric pathogen causing life-threatening diarrhoea and colitis. Microbial disruption caused by antibiotics has been linked with susceptibility to, and transmission and relapse of, C. difficile infection. Therefore, there is an urgent need for novel therapeutics that are effective in preventing C. difficile growth, spore germination, and outgrowth. In recent years bacteriophage-derived endolysins and their derivatives show promise as a novel class of antibacterial agents. In this study, we recombinantly expressed and characterized a cell wall hydrolase (CWH) lysin from C. difficile phage, phiMMP01. The full-length CWH displayed lytic activity against selected C. difficile strains. However, removing the N-terminal cell wall binding domain, creating CWH351—656, resulted in increased and/or an expanded lytic spectrum of activity. C. difficile specificity was retained versus commensal clostridia and other bacterial species.
    [Show full text]
  • Enterococcus Faecium Bacteremia Does Vancomycin Resistance Make a Difference?
    ORIGINAL INVESTIGATION Enterococcus faecium Bacteremia Does Vancomycin Resistance Make a Difference? Valentina Stosor, MD; Lance R. Peterson, MD; Michael Postelnick, RPh; Gary A. Noskin, MD Background: Enterococcus faecium has received in- eters (P=.01). Fifty-nine percent of the patients with VSE creased attention, primarily due to the emergence of van- bacteremia survived vs 24% with VRE (P=.009), despite comycin resistance. The purpose of this investigation was similar severity-of-illness scores. In 62% of the patients to study the epidemiological characteristics of vancomy- with VRE sepsis, death was related to the bacteremia cin-resistant E faecium (VRE) bacteremia and to deter- (P=.01). Patients infected with VRE had longer hospi- mine the clinical impact of vancomycin resistance on the talizations than those with VSE (34.8 vs 16.7 days, re- outcome of patients with this infection. spectively) (P=.004), were more likely to be on the medi- cal service (P=.03), and on the average, had hospitalization Methods: We retrospectively analyzed the clinical features costs of more than $27 000 per episode than did pa- and outcome of 53 patients with E faecium bacteremia. tients with VSE bloodstream infection ($83 897 vs $56 707, respectively) (P=.04). Results: From January 1992 until December 1995, there were 32 episodes of bacteremia caused by vancomycin- Conclusions: Vancomycin-resistant E faecium bactere- susceptible E faecium (VSE) and 21 caused by VRE. An mia is a complication of prolonged hospitalization in de- intra-abdominal site was the most common source of bac- bilitated patients. Vancomycin resistance has a negative teremia in both groups.
    [Show full text]
  • Identification of Clinically Relevant Streptococcus and Enterococcus
    pathogens Article Identification of Clinically Relevant Streptococcus and Enterococcus Species Based on Biochemical Methods and 16S rRNA, sodA, tuf, rpoB, and recA Gene Sequencing Maja Kosecka-Strojek 1,* , Mariola Wolska 1, Dorota Zabicka˙ 2 , Ewa Sadowy 3 and Jacek Mi˛edzobrodzki 1 1 Department of Microbiology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland; [email protected] (M.W.); [email protected] (J.M.) 2 Department of Molecular Microbiology, National Medicines Institute, 00-725 Warsaw, Poland; [email protected] 3 Department of Epidemiology and Clinical Microbiology, National Medicines Institute, 00-725 Warsaw, Poland; [email protected] * Correspondence: [email protected]; Tel.: +48-12-664-6365 Received: 13 October 2020; Accepted: 9 November 2020; Published: 11 November 2020 Abstract: Streptococci and enterococci are significant opportunistic pathogens in epidemiology and infectious medicine. High genetic and taxonomic similarities and several reclassifications within genera are the most challenging in species identification. The aim of this study was to identify Streptococcus and Enterococcus species using genetic and phenotypic methods and to determine the most discriminatory identification method. Thirty strains recovered from clinical samples representing 15 streptococcal species, five enterococcal species, and four nonstreptococcal species were subjected to bacterial identification by the Vitek® 2 system and Sanger-based sequencing methods targeting the 16S rRNA, sodA, tuf, rpoB, and recA genes. Phenotypic methods allowed the identification of 10 streptococcal strains, five enterococcal strains, and four nonstreptococcal strains (Leuconostoc, Granulicatella, and Globicatella genera). The combination of sequencing methods allowed the identification of 21 streptococcal strains, five enterococcal strains, and four nonstreptococcal strains.
    [Show full text]
  • Antibiotic Resistance Threats in the United States, 2019
    ANTIBIOTIC RESISTANCE THREATS IN THE UNITED STATES 2019 Revised Dec. 2019 This report is dedicated to the 48,700 families who lose a loved one each year to antibiotic resistance or Clostridioides difficile, and the countless healthcare providers, public health experts, innovators, and others who are fighting back with everything they have. Antibiotic Resistance Threats in the United States, 2019 (2019 AR Threats Report) is a publication of the Antibiotic Resistance Coordination and Strategy Unit within the Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention. Suggested citation: CDC. Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019. Available online: The full 2019 AR Threats Report, including methods and appendices, is available online at www.cdc.gov/DrugResistance/Biggest-Threats.html. DOI: http://dx.doi.org/10.15620/cdc:82532. ii U.S. Centers for Disease Control and Prevention Contents FOREWORD .............................................................................................................................................V EXECUTIVE SUMMARY ........................................................................................................................ VII SECTION 1: THE THREAT OF ANTIBIOTIC RESISTANCE ....................................................................1 Introduction .................................................................................................................................................................3
    [Show full text]
  • The Ecology, Epidemiology and Virulence of Enterococcus
    Microbiology (2009), 155, 1749–1757 DOI 10.1099/mic.0.026385-0 Review The ecology, epidemiology and virulence of Enterococcus Katie Fisher and Carol Phillips Correspondence University of Northampton, School of Health, Park Campus, Boughton Green Road, Northampton Katie Fisher NN2 7AL, UK [email protected] Enterococci are Gram-positive, catalase-negative, non-spore-forming, facultative anaerobic bacteria, which usually inhabit the alimentary tract of humans in addition to being isolated from environmental and animal sources. They are able to survive a range of stresses and hostile environments, including those of extreme temperature (5–65 6C), pH (4.5”10.0) and high NaCl concentration, enabling them to colonize a wide range of niches. Virulence factors of enterococci include the extracellular protein Esp and aggregation substances (Agg), both of which aid in colonization of the host. The nosocomial pathogenicity of enterococci has emerged in recent years, as well as increasing resistance to glycopeptide antibiotics. Understanding the ecology, epidemiology and virulence of Enterococcus speciesisimportant for limiting urinary tract infections, hepatobiliary sepsis, endocarditis, surgical wound infection, bacteraemia and neonatal sepsis, and also stemming the further development of antibiotic resistance. Introduction Taxonomy For many years Enterococcus species were believed to be The genus Enterococcus consists of Gram-positive, catalase- harmless to humans and considered unimportant med- negative, non-spore-forming, facultative anaerobic bacteria ically. Because they produce bacteriocins, Enterococcus that can occur both as single cocci and in chains. species have been used widely over the last decade in the Enterococci belong to a group of organisms known as food industry as probiotics or as starter cultures (Foulquie lactic acid bacteria (LAB) that produce bacteriocins Moreno et al., 2006).
    [Show full text]
  • Probiotic Potential and Antimicrobial Activity of Enterococcus Faecium Isolated from Chicken Caecal and Fecal Samples Salma H
    Food Science and Human Nutrition Publications Food Science and Human Nutrition 4-2015 Probiotic Potential and Antimicrobial Activity of Enterococcus faecium Isolated from Chicken Caecal and Fecal Samples Salma H. Abu Hafsa Arid Lands Cultivation Research Institute Aubrey F. Mendonca Iowa State University, [email protected] Byron F. Brehm-Stecher Iowa State University, [email protected] A. A. Hassan Ministry of Agriculture SF.o Allo. Iwbr thiahims and additional works at: http://lib.dr.iastate.edu/fshn_ag_pubs NortPh aCrat rofoli nthea AgFricoodultu rSacl ieanncd Tee cChnommonical State sU, nHivumersitayn and Clinical Nutrition Commons, Immunology of Infectious Disease Commons, Molecular, Genetic, and Biochemical Nutrition Commons, Organismal Biological Physiology Commons, and the Plant Sciences Commons The ompc lete bibliographic information for this item can be found at http://lib.dr.iastate.edu/ fshn_ag_pubs/173. For information on how to cite this item, please visit http://lib.dr.iastate.edu/ howtocite.html. This Article is brought to you for free and open access by the Food Science and Human Nutrition at Iowa State University Digital Repository. It has been accepted for inclusion in Food Science and Human Nutrition Publications by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Probiotic Potential and Antimicrobial Activity of Enterococcus faecium Isolated from Chicken Caecal and Fecal Samples Abstract Enterococci are important inhabitants of the animal intestine and are widely used in probiotic products. A probiotic strain is expected to possess several desirable properties in order to exert beneficial effects. Therefore, the objective of this study was to isolate, characterize and identify Enterococcus sp.
    [Show full text]